Unique QCDR Measures for 2017

We have created these EXCLUSIVE measures for you and your specialty.

MOA-1: Measure 1:

Objectifying pain and/or functionality to determine manipulative medicine efficacy with correlative treatment adjustment.

Measure Type: Outcomes
NQS Domain: Effective Clinical Care
Data Source: PM, EHR or EMR, other
Proportional or Continuous Measure: Continuous & Proportional
Inverse or Straight Measure: Straight Measure

MOA-2: Measure 2:

Appropriate use of advanced imaging by ordering provider with glucocorticoid management to spare motor neuron loss when physical findings suggest neuropathic etiology.

Measure Type: Outcomes
NQS Domain: Efficiency, Patient Care & Cost Reduction
Data Source: PM, EHR or EMR, other
Proportional or Continuous Measure: Proportional
Inverse or Straight Measure: Straight Measure

MOA-7: Measure 7:

Appropriate controlled substance prescribing (definitive diagnosis(es)) via adherence to Controlled Substance Agreements (CSA) or Opiate Agreements (OA) with corrective action taken for pain and/or substance use disorder patients when violations occur.

Measure Type: Outcomes
NQS Domain: Patient Safety, Cost Reduction (Rx)
Data Source: PM, EHR or EMR, other
Proportional or Continuous Measure: Proportional
Inverse or Straight Measure: Straight Measure

MOA-12: Measure 12:

Treatment of spinal stenosis with manipulative medicine and alternative medicine modalities.

Measure Type: Outcomes
NQS Domain: Patient Safety, Cost of Care
Data Source: PM, EHR or EMR, other
Proportional or Continuous Measure: Proportional
Inverse or Straight Measure: Straight Measure

MOA-13: Measure 13:

Urine Drug Screen Utilization in Pain Management and Substance Use Disorders; no less than quarterly for pain and no less than monthly for substance use disorders.

Measure Type: Process
NQS Domain: Patient Safety
Data Source: PM, EHR or EMR, other
Proportional or Continuous Measure: Proportional
Inverse or Straight Measure: Straight Measure

MOA-14: Measure 14:

Addressing anxiety in pain patients with SNRI and SSRIs and reducing/eliminating benzodiazepines for chronic anxiety.

Measure Type: Outcomes
NQS Domain: Patient Safety
Data Source: PM, EHR or EMR, other
Proportional or Continuous Measure: Proportional
Inverse or Straight Measure: Straight Measure

MOA-15: Measure 15:

Weight loss in pain patients with BMI >30 with opiate utilization for weight related pain conditions rather than opiate dose escalation for improved pain control.